INNOVATE Corp. VATE
7.77
0.25
3.32%
as of 25 Sep
- Market cap
- $102.6M
- P/E
- 0.0×
Follow VATE
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.16 | 0.06 | 0.05 | 0.06 | |
P/FCF ratio |
2.35 | 0.43 | 0.49 | 1.03 | |
P/Operating CF |
(10.15) | 1.67 | 0.59 | 3.38 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.51 | 0.46 | 0.44 | 0.64 | |
EV/EBITDA |
6.41 | 6.94 | 6.65 | 10.33 | |
EV/Operating CF |
5.51 | 3.01 | 3.75 | 8.04 | |
EV/FCF |
7.32 | 3.54 | 4.52 | 11.14 | |
Quick Ratio |
0.34 | 0.31 | 0.34 | 0.31 | |
Current Ratio |
0.44 | 0.40 | 0.44 | 0.43 | |
Net Debt/EBITDA |
10.44 | 23.19 | 17.59 | 32.66 | |
Debt/Assets |
61.19% | 72.54% | 63.04% | 73.27% | |
Debt/Equity |
(2.81) | (2.91) | (2.76) | (3.24) | |
Asset Turnover |
1.60 | 1.48 | 1.35 | 1.22 | |
Operating CF/Net income |
(2.37) | (2.65) | (12.96) | (2.04) | |
Capex/Depreciation |
(0.63) | (0.71) | (0.55) | (0.57) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.84% | 10.80% | 10.61% | 11.41% | |
Intangible Assets out of Total Assets |
0.15 | 0.31 | 0.16 | 0.32 | |
Share Based Compensation of Revenue |
0.09% | 0.16% | 0.13% | 0.20% | |
Graham Net Nets |
(2.99) | (10.08) | (11.98) | (10.78) | |
Graham Number |
26.60 | 41.73 | 43.21 | 45.12 | |
Earnings Yield |
(9.86%) | (74.82%) | (107.30%) | (113.70%) | |
Free Cash Flow Yield |
42.57% | 231.53% | 204.03% | 96.66% | |
Revenue per Share |
31.52 | 27.34 | 28.95 | 26.17 | |
Operating CF per Share |
(1.84) | 3.41 | 7.65 | 1.45 | |
Capex per Share |
(0.76) | (0.72) | (0.57) | (0.57) | |
Free Cash Flow per Share |
(2.60) | 2.69 | 7.08 | 0.87 | |
Cash per Share |
6.56 | 10.09 | 8.19 | 2.68 | |
Shareholders Equity per Share |
(16.37) | (17.50) | (16.41) | (15.59) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(16.37) | (17.50) | (16.41) | (15.59) | |
Free Cash Flow |
(34.80) | 35.90 | 93.60 | 11.60 | |
Working Capital |
(604.10) | (613.90) | (582.70) | (553.70) | |
Capital Expenditures |
(10.20) | (9.60) | (7.50) | (7.60) | |
Net Current Asset Value |
(746.30) | (764.40) | (715.60) | (699.40) | |
EV/EBIT |
11.99 | 17.59 | 19.18 | 41.33 | |
Capex to Sales |
0.02 | 0.03 | 0.02 | 0.02 | |
Net Profit Margin |
2.47% | (4.71%) | (2.04%) | (2.71%) | |
Price to Operating Income |
3.85 | 2.15 | 2.08 | 3.84 | |
| Other line items | |||||
Average Receivables |
263.55 | 175.25 | 216.70 | 228.20 | |
Average Payables |
108.70 | 117.45 | 112.65 | 91.80 | |
Average Inventory |
17.75 | 17.55 | 18.40 | 19.55 | |
Average Assets |
948.80 | 902.40 | 920.60 | 905.20 | |
Average Common Equity |
(217.50) | (213.65) | (192.75) | (178.50) |
Columns are period end dates